Introducing The Lancet Digital Health

Hugo Aerts and Ray Mak from Mass General Brigham join Lucy Dunbar to discuss FaceAge, a deep learning tool that estimates biological age from simple face photographs, and its implications in aiding clinicians in predicting prognoses for people with cancer.Read the full article:ht ...  Afficher plus

Mohamed Omar joins The Lancet Digital Health to discuss pathology and generative AI from a Digital Health Perspective. We explore expert journeys, AI applications in diagnostics, GPT-4's role, integration challenges, ethical considerations, democratisation of knowledge, and futur ...  Afficher plus

Can a multi-metabolite blood test improve early pancreatic cancer detection? We spoke to Julia Mayerle about the METAPAC study, which sought to validate the ability of plasma metabolic signatures to find resectable tumors and reduce unnecessary invasive procedures in high-risk ...

Ninja Nerds!
In this episode of the Ninja Nerd Podcast, Zach and Rob explore pancreatic and hepatobiliary cancers through four patient cases packed with clinical pearls.

We begin with a 63-year-old man presenting with painless jaundice, pruritus, and weight loss. ...

Breast cancer is the most common cancer among women globally. And yet, many people pass up opportunities to get screened for the disease, often because of the invasive and sometimes painful process of mammograms. Chemist and professor Simona Francese presents a potentially ground ...  Afficher plus

In this episode of OncoTalks, Dr. Paul Conkling and Dr. Kashif Ali explore how minimal residual disease (MRD) testing using circulating tumor DNA (ctDNA) is reshaping breast cancer management. They discuss how this innovative approach enables the detection of molecular disease ...